The study, published in Journal of Infectious Diseases, found that those with hepatitis C who completed treatment and received another hepatitis B vaccination had an improved response.
Researchers encourage patients to be tested for hepatitis B immune protection and if there is none, should be vaccinated again after treating hepatitis C.
“It is known that the hepatitis B vaccine is not as effective in those with hepatitis C,” Jose Debes, MD, PhD, an associate professor in the schools of medicine and public health, said in a University of Minnesota Medical School news release. “What was not known until now is that after treating hepatitis C the hepatitis B vaccine seems to be more effective in this population. This is important, as many of these individuals are still at risk for hepatitis B infection.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.